Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational
Official Title: Optimisation of Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
Brief Summary: The study aims to evaluate the biochemical and clinical effectiveness on symptoms and tumor size of a monotherapy with Lanreotide 120mg in acromegalic subjects, to describe criteria for starting alternative strategies, and to describe the modalities and the global effectiveness of alternative strategies.